Nebenwirkungen · Entacapone Teva
Entacapone Teva 200 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 5
HOS-213546 · Präparat HOS-155128
Summary of the safety profile The most frequent adverse reactions caused by entacapone relate to the increased dopaminergic activity and occur most commonly at the beginning of the treatment. Reduction of levodopa dosage decreases the severity and frequency of these reactions. The other major class of adverse reactions are gastrointestinal symptoms, including nausea, vomiting, abdominal pain, constipation and diarrhoea. Urine may be discoloured reddish-brown by entacapone, but this is a harmless phenomenon.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2021-09-28T17:49:00Z · SHA-256 a1bd223632cc773f7d6b9c4c6c3717b6bb040156eb55488dc0e81428b647ce20 · Passage c6977efa708a458979fe441f35cc9ddf6dd5f5e06fc2fd1b308fa0e721cafc6d · Zeichen 0–512 im Abschnitt